Citigroup’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653M Sell
1,352,136
-160,918
-11% -$42.7M 0.22% 85
2026
Q1
$166M Buy
1,513,054
+584,724
+63% +$83.3M 0.07% 254
2025
Q4
$154M Buy
928,330
+45,136
+5% +$7.55M 0.07% 254
2025
Q3
$173M Buy
883,194
+213,453
+32% +$35.1M 0.08% 251
2025
Q2
$60.6M Buy
669,741
+208,648
+45% +$16.5M 0.03% 526
2025
Q1
$27.5M Buy
461,093
+403,201
+696% +$37.3M 0.01% 809
2024
Q4
$7.67M Buy
57,892
+13,365
+30% +$1.25M ﹤0.01% 1587
2024
Q3
$2.33M Buy
44,527
+43,985
+8,115% +$2.06M ﹤0.01% 2525
2024
Q2
$32.8K Buy
+542
New +$37.6K ﹤0.01% 4811

Other funds holding ALAB

Citigroup's ALAB Position: Q2 2026 in Review

Citigroup reduced its Astera Labs (ALAB) stake by 11% in Q2 2026, selling an estimated $42.7M and leaving 1,352,136 shares worth $653M. The position accounts for 0.22% of the portfolio, ranked #85.

Citigroup first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Citigroup held 1,352,136 shares of Astera Labs worth $653M as of Q2 2026.
  • Citigroup sold 160,918 Astera Labs shares in Q2 2026, an estimated $42.7M.
  • Astera Labs made up 0.22% of Citigroup's portfolio in Q2 2026, its #85 holding.
  • Citigroup first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.